Published in J Virol on July 01, 1982
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
Primary structure of leader RNA and nucleoprotein genes of the rabies genome: segmented homology with VSV. Nucleic Acids Res (1986) 1.53
Sequence determination of the (+) leader RNA regions of the vesicular stomatitis virus Chandipura, Cocal, and Piry serotype genomes. J Virol (1983) 1.11
Formation of guanosine(5')tetraphospho(5')adenosine cap structure by an unconventional mRNA capping enzyme of vesicular stomatitis virus. J Virol (2008) 1.02
ATP dependence of vesicular stomatitis virus transcription initiation and modulation by mutation in the nucleocapsid protein. J Virol (1984) 0.99
Two transcription products of the vesicular stomatitis virus genome may control L-cell protein synthesis. J Virol (1983) 0.87
Initiation of RNA synthesis in vitro by vesicular stomatitis virus: single internal initiation in the presence of aurintricarboxylic acid and vanadyl ribonucleoside complexes. Nucleic Acids Res (1983) 0.85
Signature motifs of GDP polyribonucleotidyltransferase, a non-segmented negative strand RNA viral mRNA capping enzyme, domain in the L protein are required for covalent enzyme-pRNA intermediate formation. Nucleic Acids Res (2015) 0.82
Capping of vesicular stomatitis virus pre-mRNA is required for accurate selection of transcription stop-start sites and virus propagation. Nucleic Acids Res (2014) 0.81
In vitro synthesis of large RNAs by an unusual defective interfering particle of vesicular stomatitis virus. J Virol (1988) 0.75
Mapping adenines, guanines, and pyrimidines in RNA. Nucleic Acids Res (1977) 26.63
New rapid gel sequencing method for RNA. Nature (1977) 9.56
Order of transcription of genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 7.61
Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 5.88
Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell (1980) 5.32
Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus N and NS proteins. J Virol (1981) 4.49
The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43
A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell (1976) 3.82
Degradation of DNA RNA hybrids by ribonuclease H and DNA polymerases of cellular and viral origin. Proc Natl Acad Sci U S A (1972) 3.58
Vesicular stomatitis virus: mode of transcription. J Gen Virol (1977) 3.53
Heterogneeous 5'-terminal structures occur on vesicular stomatitis virus mRNAs. J Biol Chem (1975) 3.44
Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus. Cell (1978) 3.06
5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73
Unique mode of transcription in vitro by Vesicular stomatitis virus. Cell (1980) 2.36
The complete sequence of a unique RNA species synthesized by a DI particle of VSV. Cell (1978) 2.04
Complete sequences of the ribosome recognition sites in vesicular stomatitis virus mRNAs: recognition by the 40S and 80S complexes. Cell (1978) 1.97
Dinucleoside pyrophosphate are substrates for T4-induced RNA ligase. Proc Natl Acad Sci U S A (1977) 1.94
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA. J Virol (1980) 1.76
Analysis of RNA initiated in isolated mouse myeloma nuclei using purine nucleoside 5'[gamma-S]triphosphates as affinity probes. Cell (1978) 1.73
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles. Cell (1979) 1.72
In vivo transcription of the 5'-terminal extracistronic region of vesicular stomatitis virus RNA. J Virol (1981) 1.56
In vitro synthesis of triphosphate-initiated N-gene mRNA oligonucleotides is regulated by the matrix protein of vesicular stomatitis virus. J Virol (1982) 1.42
Identification of promoter-proximal oligonucleotides and a unique dinucleotide, pppGpC, from in vitro transcription products of vesicular stomatitis virus. J Virol (1981) 1.38
The 5' sequences of VSV in vitro transcription product RNA (+/-SAM). Biochem Biophys Res Commun (1976) 1.18
Identification and characterization of a group of discrete initiated oligonucleotides transcribed in vitro from the 3' terminus of the N-gene of vesicular stomatitis virus. J Virol (1982) 1.13
The 5' terminal nucleotide of RNA from vesicular stomatitis virus defective interfering particles. Virology (1977) 1.09
Adenosine-5'-O-(3-thiotriphosphate) as an affinity probe for studying leader RNA's transcribed by vesicular stomatitis virus. J Biol Chem (1979) 1.05
Structure and origin of a snapback defective interfering particle RNA of vesicular stomatitis virus. J Virol (1981) 0.97
Synthesis of carrier-free beta-32P-nucleosides-triphosphate in almost quantitative yields. Anal Biochem (1980) 0.93
The metabolic fate of independently initiated VSV mRNA transcripts. J Gen Virol (1982) 0.92
Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14
The characterization of soluble amyloid prepared in water. J Clin Invest (1968) 6.17
An improved method for thin-layer chromatography of nucleotide mixtures containing 32P-labelled orthophosphate. J Chromatogr (1969) 5.67
Polyadenylation sites for influenza virus mRNA. J Virol (1981) 4.42
On the regulation of guanosine tetraphosphate levels in stringent and relaxed strains of Escherichia coli. J Biol Chem (1971) 3.69
Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations. J Virol (1984) 3.54
The origins of defective interfering particles of the negative-strand RNA viruses. Cell (1981) 3.50
The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat Genet (2000) 3.49
CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell (1999) 3.39
Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein. J Virol (1983) 3.30
Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A (1996) 3.07
Analysis of the RNA of defective VSV particles. Cell (1974) 2.92
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J (1987) 2.72
Alternative splicing accounts for the four forms of myelin basic protein. Cell (1985) 2.61
Differences in lysine-sRNA from spore and vegetative cells of Bacillus subtillis. Proc Natl Acad Sci U S A (1966) 2.50
IRS-2 pathways integrate female reproduction and energy homeostasis. Nature (2000) 2.45
Medium-dependent alteration of lysine transfer ribonucleic acid in sporulating Bacillus subtilis cells. J Bacteriol (1967) 2.43
Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis. Cell (1985) 2.38
Expression of a cDNA encoding a functional 241-kilodalton vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (1985) 2.28
The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it. EMBO J (1988) 2.21
The development of subretinal microphotodiodes for replacement of degenerated photoreceptors. Ophthalmic Res (1997) 2.20
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
Diffusion of innovative health care services in the United States: a study of hospitals. Med Care (1971) 2.15
Prevalence and determinants of nutritional blindness in Bangladeshi children. World Health Stat Q (1985) 2.12
Covalently linked message and anti-message (genomic) RNA from a defective vesicular stomatitis virus particle. J Mol Biol (1975) 2.11
Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol (1990) 2.05
The complete sequence of a unique RNA species synthesized by a DI particle of VSV. Cell (1978) 2.04
Location of the binding domains for the RNA polymerase L and the ribonucleocapsid template within different halves of the NS phosphoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1987) 2.03
The control of ribonucleic acid synthesis during amino acid deprivation in Escherichia coli. J Biol Chem (1971) 2.02
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
Magnetic brain stimulation with a double coil: the importance of coil orientation. Electroencephalogr Clin Neurophysiol (1992) 1.91
Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc Natl Acad Sci U S A (1988) 1.87
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved. J Virol (1979) 1.87
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
The Hox-1.3 homeo box protein is a sequence-specific DNA-binding phosphoprotein. Genes Dev (1989) 1.83
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA. J Virol (1980) 1.76
Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74
Expression of a homeo domain protein in noncontact-inhibited cultured cells and postmitotic neurons. Genes Dev (1987) 1.74
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles. Cell (1979) 1.72
Cloning and expression of a viral phosphoprotein: structure suggests vesicular stomatitis virus NS may function by mimicking an RNA template. J Gen Virol (1986) 1.66
Recombination within the myelin basic protein gene created the dysmyelinating shiverer mouse mutation. Proc Natl Acad Sci U S A (1986) 1.65
A comparison of proteinpolysaccharides of bovine nasal cartilage isolated and fractionated by different methods. J Biol Chem (1970) 1.65
Stereo images of vesicular stomatitis virus assembly. J Virol (1986) 1.63
The separation of new forms of the proteinpolysaccharides of bovine nasal cartilage. J Biol Chem (1966) 1.61
Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J Neurosci (1996) 1.60
Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions. Oral Surg Oral Med Oral Pathol (1994) 1.58
In vivo transcription of the 5'-terminal extracistronic region of vesicular stomatitis virus RNA. J Virol (1981) 1.56
Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol (1998) 1.53
Vesicular stomatitis virus defective interfering particle containing a muted internal leader RNA gene. Proc Natl Acad Sci U S A (1981) 1.53
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content. J Cell Biol (1998) 1.51
Direct visualization of protein transport and processing in the living cell by microinjection of specific antibodies. Cell (1984) 1.48
Visual influence on human locomotion. Modulation to changes in optic flow. Exp Brain Res (1997) 1.47
F waves and motor unit size. Muscle Nerve (1992) 1.46
SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials. Neurology (2006) 1.44
Proteinpolysaccharides from human articular and costal cartilage. J Clin Invest (1965) 1.43
Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression. J Cell Biol (1992) 1.43
Virus-induced autoantibody response to a transgenic viral antigen. Nature (1990) 1.42
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs. J Virol (1984) 1.40
Characterization of the 3' terminus of RNA isolated from vesicular stomatitis virus and from its defective interfering particles. Proc Natl Acad Sci U S A (1977) 1.40
The mouse Hox-1.3 gene is functionally equivalent to the Drosophila Sex combs reduced gene. Genes Dev (1993) 1.40
A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet (1996) 1.39
Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol (1994) 1.39
Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc Natl Acad Sci U S A (2000) 1.39
Structure of connective tissues, a chemical point of view. Fed Proc (1966) 1.38
The rates of synthesis and chain elongation of ribonucleic acid in Escherichia coli. J Biol Chem (1969) 1.38
The proteinpolysaccharides of bovine nucleus pulposus. J Biol Chem (1967) 1.38
High frequency of submicroscopic genomic aberrations detected by tiling path array comparative genome hybridisation in patients with isolated congenital heart disease. J Med Genet (2008) 1.37
Defective interfering particle generated by internal deletion of the vesicular stomatitis virus genome. J Virol (1980) 1.36
Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J Cell Biol (1986) 1.36
A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products. Cytotherapy (2008) 1.35
Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L. J Virol (1987) 1.35
The relationship between autointerference and the replication of defective interfering particle. Virology (1977) 1.33
Requirement of heavy neurofilament subunit in the development of axons with large calibers. J Cell Biol (1998) 1.32
Responses of single spinal motoneurons to magnetic brain stimulation in healthy subjects and patients with multiple sclerosis. Brain (1991) 1.32
The interaction of monosodium urate with connective tissue components. J Clin Invest (1970) 1.32
Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med (1989) 1.29
Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles. J Virol (1992) 1.28
The chordate amphioxus: an emerging model organism for developmental biology. Cell Mol Life Sci (2004) 1.26
Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells. Proc Natl Acad Sci U S A (1988) 1.26